Abstract:Background: Head and neck cancer is the sixth most common malignancy worldwide, and oral squamous cell carcinoma (OSCC) is the most common head and neck cancer, being one of the leading causes of cancer morbidity and mortality worldwide. CC Chemokine receptor 7(CCR7) is a multifunctional G protein-coupled trans-membrane chemokine that affects immune cell chemotaxis, migration, and cancer progression through its interaction with its ligands C-C motif chemokine ligand 19(CCL19) and C-C motif chemokine ligand 21(CCL21). Numerous studies have demonstrated the involvement of CCR7 in the malignant progression of a variety of cancers, reflecting the pro-cancer properties of CCR7. The Cancer Genome Atlas data suggests CCR7 has elevated expression in oral cancer. Specifically, CCR7 expression in tumor microenvironment (TME) may regulate the ability of some immune cells to engage in anti-tumor immune responses. Since CD8+ T cells have become a key immunotherapeutic target, the role of CCR7 in antitumor immune response of naïve CD8+ T cells in TME has not been thoroughly investigated. Methods: A CCR7 knockout mouse model was constructed, and the mechanism of ccr7 on the regulation of tumor microenvironment by naïve CD8+ T cells was verified under the guidance of single-cell RNA sequencing combined with in vivo animal experiments and in vitro cell experiments. Results: CCR7 is knocked out with impaired tumor growth and altered CD8+ T cell profiles, revealing the importance of this protein in OSCC. Conclusions: Inhibition of CCR7 enhances CD8+ T cell activation, proliferation, and anti-tumor function, suggesting its potential as a therapeutic target.

Crucial Biological Functions of CCL7 in Cancer

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer

CXCR7 in tumorigenesis and progression.

CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck

High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.

CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease

Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CCR7 affects the tumor microenvironment by regulating the activation of naïve CD8+ T cells to promote the proliferation of oral squamous cell carcinoma

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment

Effect of CXCR7 on Tumor Development,Angiogenesis and Immune Reaction

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

The CCL20-CCR6 Axis in Cancer Progression

The Role of CXCR3 and Its Ligands in Cancer

Expression and Regulation Effects of Chemokine Receptor 7 in Colon Cancer Cells

Chemokine CCL20 and malignant tumors

Ccr7 Mediates Human Breast Cancer Cell Invasion, Migration by Inducing Epithelial-Mesenchymal Transition and Suppressing Apoptosis Through Akt Pathway

The role of CCL8 in immune regulation of diseases

The regulatory network of the chemokine CCL5 in colorectal cancer

CCL20 and its receptor CCR6 in digestive system tumors